Acute coronary syndromes: diagnosis and management, part I

Area of Science:

• Cardiology
• Internal Medicine

Background:

• Acute coronary syndrome (ACS) encompasses conditions like unstable angina (UA), non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI).
• These conditions represent high-risk manifestations of coronary atherosclerosis, frequently leading to emergency medical care and hospitalization in the U.S.

Purpose of the Study:

• To summarize current evidence on ACS pathophysiology, clinical presentation, and risk stratification.
• To provide clinicians with the latest information on managing UA/NSTEMI.

Main Methods:

• Review of patient history, physical examination, electrocardiography, radiologic studies, and cardiac biomarker tests for diagnosis and risk stratification.
• Analysis of evidence-based guidelines and large-scale randomized controlled trials for therapeutic approaches.

Main Results:

• Accurate diagnosis and early risk stratification are crucial for guiding treatment decisions in ACS.
• High-risk UA/NSTEMI patients often benefit from an early invasive strategy, including cardiac catheterization and revascularization.
• Optimizing clinical outcomes involves combining revascularization with comprehensive medical therapy (anti-ischemic, antiplatelet, anticoagulant, lipid-lowering).

Conclusions:

• Management of ACS is evolving rapidly, driven by ongoing research and clinical trials.
• Clinicians must stay informed to select optimal drug therapies and treatment strategies for ACS patients.
• Effective ACS management requires a multi-faceted approach integrating diagnostic assessment, risk stratification, invasive procedures, and aggressive medical treatment.